Le Lézard
Classified in: Health
Subjects: AWD, MAT

Dr. Rod J. Rohrich Recognized as Best Facelift Surgeon in the United States by Newsweek


Dallas plastic surgeon, Dr. Rod J. Rohrich, has recently been recognized by Newsweek as the best facelift surgeon in the United States for the second consecutive year in their ranked list of top performing plastic surgeons.

DALLAS, Oct. 6, 2022 /PRNewswire-PRWeb/ -- Dallas plastic surgeon, Dr. Rod J. Rohrich, has been ranked as the top facelift surgeon in the United States in Newsweek's new peer reviewed list of top performing plastic surgeons for the second consecutive year.

Working with data analytics provider, Statista Inc., Newsweek has published a ranked list of the best plastic surgeons in the United States in each of five different categories of the most commonly performed cosmetic surgery procedures: breast augmentation, liposuction, facelift, eye lift, and rhinoplasty.

These lists were developed as the result of a national survey with more than 2,000 industry experts from doctors, surgeons, plastic surgery clinic managers, and health care professionals working in plastic surgery. The associated quality score is based on each candidate's surgical preparation, surgical process, post-operative follow-up care, and overall surgical outcomes generating over 5,900 votes. The survey identified 349 individual surgeons which were then ranked into lists of the top 150 in each of the five specialties, with the specific rankings based on their final quality score.

Dr. Rohrich was ranked at number 1 for best facelift surgeon in the United States, with the top score of 93.21% based on their unique scoring system. Dr. Rohrich also appeared in the other lists at number 1 in rhinoplasty, third in liposuction, fourth in eyelifts which might often be included as part of a facelift, and sixth in breast augmentation.

"Individual facial analysis is one of the most important steps in providing the highest quality outcomes for facelift patients," says Dr. Rohrich, who writes and lectures extensively on facelift surgery. "Every person ages differently and each component of a facelift must be tailored to the patient's specific situation and their unique facial features and anatomy. We must take into account not only that the face must look natural and youthful, but also how it looks after the patient heals and how the results will age along with the person."

According to Dr. Rohrich, facelift outcomes tend to be better when they are performed as a "lift and fill" facelift combined with fat augmentation to address fat atrophy. The use of science based skin care, including daily applications of Retin-A, sun avoidance, and smoking cessation, help to deliver improved and longer lasting results. In addition to making sure to address the neck area during a facelift, better results have also been associated with performing additional complementary procedures such as eyelid surgery and skin resurfacing.

"I'm extremely honored to have my work in facelift surgery recognized by Newsweek in this extensive peer reviewed process," says Dr. Rohrich. "These types of awards are valuable tools that can help guide patients toward well qualified facelift surgeons as surgeon selection is the single most important factor for ensuring a successful outcome in plastic surgery."

About Rod J. Rohrich, M.D., F.A.C.S.

Dr. Rod J. Rohrich is a board certified plastic surgeon in Dallas, Texas. He is considered one of the most influential surgeons in this century. He was named the top plastic surgeon in America by Newsweek in both rhinoplasty and facelift surgery in 2022 as well as 2021. Dr. Rohrich is a Clinical Professor of Plastic Surgery at Baylor College of Medicine. He was the first Chair of the Department of Plastic Surgery as well as the first plastic surgeon selected as a Distinguished Teaching Professor at UT Southwestern Medical Center. He graduated from Baylor College of Medicine with high honors, and completed his plastic surgery training at the University of Michigan Medical Center and fellowships at Massachusetts General Hospital/Harvard (hand/microsurgery) and Oxford University (pediatric plastic surgery). He is Chair of the Dallas Rhinoplasty Meeting, Founding Chair of the Dallas Cosmetic Surgery and Medicine Meeting, Founding Member of the Alliance in Reconstructive Surgery, and a Founding Partner of the Dallas Plastic Surgery Institute.

He is the immediate past (after serving for 18 years) Editor-in-Chief of the most respected global peer reviewed plastic surgery journal ? the Plastic and Reconstructive Surgery Journal. He is Founding Editor-in-Chief/Editor Emeritus of the first open access peer reviewed plastic surgery journal, PRS Global Open. Dr. Rohrich has published over 1000 peer reviewed articles and seven textbooks in plastic surgery including a best-selling medical book entitled The Facial Danger Zones. Dr. Rohrich recently published an innovative cosmetic surgery video atlas, Cosmetic Surgery by the Masters.

Dr. Rohrich also served as president of the American Society of Plastic Surgeons (ASPS), the largest organization of board certified plastic surgeons in the world. He repeatedly has been selected by his peers as one of America's best doctors. He received the ASPS Special Achievement Award and on three occasions has received one of his profession's highest honors, the Plastic Surgery Foundation (PSF) Distinguished Service Award, which recognizes his contributions to education in plastic surgery. In addition, he has also been recognized by the PSF with the Plastic Surgery Foundation Distinguished Career Researcher Award for his contributions to plastic surgery research and innovations.

Media Contact

Rod J. Rohrich, MD, Dallas Plastic Surgery Institute, (214) 821-9114, [email protected]

 

SOURCE Dr. Rod J. Rohrich


These press releases may also interest you

at 03:00
Global biotechnology leader CSL Behring today announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at Hemophilia Treatment Centers in France. This milestone achievement makes HEMGENIX® the...

at 02:30
SOPHiA GENETICS , a cloud-native healthcare technology company and a global leader in data-driven medicine, today announced that Dhiti Omics Technologies, a precision molecular diagnostics service provider in India, is live on the SOPHiA...

at 01:15
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that the Phase II/III SKYSCRAPER-06 study, evaluating tiragolumab plus Tecentriq® (atezolizumab) and chemotherapy versus pembrolizumab and chemotherapy as an initial...

at 01:05
BenevolentAI ("BenevolentAI" or the "Company") (Euronext Amsterdam: BAI), a leader in applying advanced AI to accelerate biopharma drug discovery, announces the appointment of Deutsche Numis as the Company's Financial and Capital Markets Adviser,...

3 jui 2024
YOUR LEGAL RIGHTS MAY BE AFFECTED There is a proposed settlement in a class-action lawsuit filed against Pfizer Inc., Pfizer Ireland Pharmaceuticals, Warner-Lambert Company, and Warner-Lambert Company LLC (collectively, "Pfizer") and Ranbaxy Inc.,...

3 jui 2024
In a landmark event signaling its ambitious foray into the biopharmaceutical sector, LOTTE BIOLOGICS, under the leadership of CEO Richard W. Lee, held a groundbreaking ceremony for its inaugural plant at the Songdo Bio Campus in Incheon International...



News published on and distributed by: